SC 13G Filing

Company

Celldex Therapeutics, Inc.

Filed

July 7, 2005

Accession Number

0000898432-05-000536

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →